Country percentage share by public sector of antimalarial treatments over the period under study

<p><b>Copyright information:</b></p><p>Taken from "Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)"</p><p>http://www.malariajournal.com/content/6/1/91</p><p>Malaria Journal 2007;6():91-91.</p><p>Published online 10 Jul 2007</p><p>PMCID:PMC1948000.</p><p></p

Characteristics of FGD participants.

<p>Characteristics of FGD participants.</p

Overview of participants in qualitative study.

<p>Overview of participants in qualitative study.</p

Outline of Pro-ACD activities.

<p>Outline of Pro-ACD activities.</p

Flow Chart of Sites and Type of MSF Pf Efficacy Studies, 1996–2004

<p>Flow Chart of Sites and Type of MSF Pf Efficacy Studies, 1996–2004</p

Number of MSF Pf Efficacy Studies and Treatment Groups (Monotherapies and ACT) Per Year of Completion, 1996–2004

<p>Cells with X represent studies of 14-day follow-up or less; empty cells represent studies of 28-day follow-up or more. Mono = monotherapies.</p